Technological capability building in Iranian biosimilar industry Online publication date: Mon, 01-Feb-2021
by Razieh Ahmady; Gholamhossein Mehralian
International Journal of Technological Learning, Innovation and Development (IJTLID), Vol. 12, No. 4, 2020
Abstract: The development of technological capability plays a strategic role in industrialisation and catchup in developing countries. However, the emergence of new technologies, coupled with industries' ever-shifting business models, has affected the processes and factors critical to the formation of technological capability. In this context, the present study seeks to investigate the pattern of technological capability building in the Iranian firms to the emergence of the biosimilar sector in the pharmaceutical market. Drawing on a case study strategy, the findings reveal that the path of capability evolution in Iranian firms is shaped by a gradual movement towards acquiring biosimilar capabilities. This paper also shows that firms relying on a combination of indigenous research and development as well as technological collaborations make most progress in the capability building. Furthermore, scientific collaborations with research institutes, hiring experts in biotechnology and organisational capability development are key strategies contributing to the accumulation of technological capabilities in Iranian biosimilar firms.
Online publication date: Mon, 01-Feb-2021
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Technological Learning, Innovation and Development (IJTLID):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email email@example.com